Science and Determination Take on Cancer
There is still a long way to go before cancer becomes a consistently preventable, treatable disease. But we see signs of real progress every day in our labs and in our patients’ lives.
IU Simon Cancer Center researchers have made discoveries that have altered or defined treatment standards for the following diseases:
- Breast cancer
- Gastrointestinal cancer, including pancreatic and colon cancers
- Genitourinary cancer, including germ cell tumors and bladder and prostate cancers
- Hematologic disorders, including multiple myeloma and leukemia
- Thoracic cancer
- Thymoma and thymic carcinoma
Pioneers in Testis Cancer and Related Chemotherapies
In 1974, IU Simon Cancer Center researcher Lawrence Einhorn, M.D., developed the curative chemotherapy regimen for testis cancer and was instrumental in the approval of cisplatin, etoposide and ifosfamide by the FDA. Today, nearly 95 percent of patients with testis cancer survive the disease, and platinum-based chemotherapy has been used to successfully treat ovarian, small cell lung and germ cell tumors.
IU Simon Cancer Center Houses the World’s First Healthy Breast Tissue Bank
In 2007, the Susan G. Komen Tissue Bank at the IU Simon Cancer Center was established. It’s the world’s first tissue bank for healthy breast tissue. The bank collects tissues from women without breast cancer to identify biomarkers that may one day lead to better prevention and treatment of the disease.
Read about the tissue bank’s impact on breast cancer research 10 years after its founding. Go to page 4 in the 2017 IU Simon Cancer Center scientific report.
A Commitment to Tackling Pancreatic Cancer
Two IU Simon Cancer Center researchers earned a $3.2 million grant that will be used to develop and improve therapies, offering new hope for those with pancreatic cancer.